• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

免疫细胞信号传导:一种新型机制模型揭示了新的治疗靶点。

Immune cell signaling: a novel mechanistic model reveals new therapeutic targets.

作者信息

Sigalov Alexander B

机构信息

Department of Pathology, University of Massachusetts Medical School, 55 Lake Avenue North, Worcester, MA 01655, USA.

出版信息

Trends Pharmacol Sci. 2006 Oct;27(10):518-24. doi: 10.1016/j.tips.2006.08.004. Epub 2006 Aug 14.

DOI:10.1016/j.tips.2006.08.004
PMID:16908074
Abstract

Multichain immune recognition receptors (MIRRs) represent a family of surface receptors that is expressed on different cells and that transduces extracellular signals, leading to many biological responses. The most intriguing common structural feature of MIRR family members is that the extracellular recognition domains and the intracellular signaling domains are located on separate subunits. It is not clear how extracellular ligand binding triggers MIRRs and initiates intracellular signal-transduction processes. In this article, I suggest that the structural similarity of the MIRRs provides the basis for the similarity in the mechanisms of MIRR-mediated transmembrane signaling. This hypothesis assumes that the therapeutic strategies learned from a novel mechanistic model of MIRR-mediated signal transduction, the signaling chain homo-oligomerization model, are generalized for this entire family and have important implications for the treatment of many disorders that are mediated by immune cells, including HIV.

摘要

多链免疫识别受体(MIRRs)代表一类表面受体家族,其在不同细胞上表达并转导细胞外信号,从而引发多种生物学反应。MIRR家族成员最引人关注的共同结构特征是,细胞外识别结构域和细胞内信号传导结构域位于不同的亚基上。目前尚不清楚细胞外配体结合如何触发MIRRs并启动细胞内信号转导过程。在本文中,我认为MIRRs的结构相似性为MIRR介导的跨膜信号传导机制的相似性提供了基础。这一假设认为,从MIRR介导的信号转导新机制模型——信号链同源寡聚化模型中学到的治疗策略,可推广至整个家族,并对治疗包括HIV在内的许多由免疫细胞介导的疾病具有重要意义。

相似文献

1
Immune cell signaling: a novel mechanistic model reveals new therapeutic targets.免疫细胞信号传导:一种新型机制模型揭示了新的治疗靶点。
Trends Pharmacol Sci. 2006 Oct;27(10):518-24. doi: 10.1016/j.tips.2006.08.004. Epub 2006 Aug 14.
2
Signaling chain homooligomerization (SCHOOL) model.信号链同源寡聚化(SCHOOL)模型。
Adv Exp Med Biol. 2008;640:121-63. doi: 10.1007/978-0-387-09789-3_12.
3
Transmembrane interactions as immunotherapeutic targets: lessons from viral pathogenesis.作为免疫治疗靶点的跨膜相互作用:来自病毒发病机制的经验教训
Adv Exp Med Biol. 2007;601:335-44. doi: 10.1007/978-0-387-72005-0_36.
4
Multi-chain immune recognition receptors: spatial organization and signal transduction.多链免疫识别受体:空间组织与信号转导
Semin Immunol. 2005 Feb;17(1):51-64. doi: 10.1016/j.smim.2004.09.003.
5
New therapeutic strategies targeting transmembrane signal transduction in the immune system.针对免疫系统跨膜信号转导的新治疗策略。
Cell Adh Migr. 2010 Apr-Jun;4(2):255-67. doi: 10.4161/cam.4.2.10746. Epub 2010 Apr 24.
6
SCHOOL model and new targeting strategies.SCHOOL模型与新的靶向策略。
Adv Exp Med Biol. 2008;640:268-311. doi: 10.1007/978-0-387-09789-3_20.
7
Multichain immune recognition receptor signaling: different players, same game?多链免疫识别受体信号传导:不同参与者,相同游戏?
Trends Immunol. 2004 Nov;25(11):583-9. doi: 10.1016/j.it.2004.08.009.
8
Triggering receptor expressed on myeloid cells-1 (TREM-1) amplifies the signals induced by the NACHT-LRR (NLR) pattern recognition receptors.髓系细胞表达的触发受体-1(TREM-1)可放大由NACHT-亮氨酸富集重复序列(NLR)模式识别受体诱导的信号。
J Leukoc Biol. 2006 Dec;80(6):1454-61. doi: 10.1189/jlb.1205758. Epub 2006 Aug 29.
9
Protein intrinsic disorder and oligomericity in cell signaling.细胞信号传导中的蛋白质内在无序性和寡聚性
Mol Biosyst. 2010 Mar;6(3):451-61. doi: 10.1039/b916030m. Epub 2009 Nov 3.
10
Lipid-binding activity of intrinsically unstructured cytoplasmic domains of multichain immune recognition receptor signaling subunits.多链免疫识别受体信号亚基的内在无序细胞质结构域的脂质结合活性。
Biochemistry. 2006 Dec 26;45(51):15731-9. doi: 10.1021/bi061108f. Epub 2006 Dec 19.

引用本文的文献

1
TREM-1 and TREM-2 as therapeutic targets: clinical challenges and perspectives.以触发受体表达于髓细胞-1(TREM-1)和触发受体表达于髓细胞-2(TREM-2)作为治疗靶点:临床挑战与前景
Front Immunol. 2024 Dec 16;15:1498993. doi: 10.3389/fimmu.2024.1498993. eCollection 2024.
2
Inhibition of TREM-2 Markedly Suppresses Joint Inflammation and Damage in Experimental Arthritis.抑制 TREM-2 显著抑制实验性关节炎的关节炎症和损伤。
Int J Mol Sci. 2022 Aug 9;23(16):8857. doi: 10.3390/ijms23168857.
3
Novel ligands and modulators of triggering receptor expressed on myeloid cells receptor family: 2015-2020 updates.
触发受体表达于髓系细胞家族的新型配体和调节剂:2015-2020 年更新。
Expert Opin Ther Pat. 2021 Jun;31(6):549-561. doi: 10.1080/13543776.2021.1883587. Epub 2021 Feb 8.
4
SCHOOL of nature: ligand-independent immunomodulatory peptides.自然学派:配体非依赖性免疫调节肽。
Drug Discov Today. 2020 Aug;25(8):1298-1306. doi: 10.1016/j.drudis.2020.05.005. Epub 2020 May 12.
5
Commentary: Triggering Receptor Expressed on Myeloid Cells-1 Inhibitor Targeted to Endothelium Decreases Cell Activation.述评:靶向内皮细胞的髓样细胞表达触发受体-1抑制剂可降低细胞活化。
Front Immunol. 2020 Feb 11;11:173. doi: 10.3389/fimmu.2020.00173. eCollection 2020.
6
Extracellular CIRP as an endogenous TREM-1 ligand to fuel inflammation in sepsis.细胞外 CIRP 作为内源性 TREM-1 配体在脓毒症中引发炎症。
JCI Insight. 2020 Mar 12;5(5):134172. doi: 10.1172/jci.insight.134172.
7
Inhibition of Triggering Receptor Expressed on Myeloid Cells 1 Ameliorates Inflammation and Macrophage and Neutrophil Activation in Alcoholic Liver Disease in Mice.抑制髓样细胞表达的触发受体1可改善小鼠酒精性肝病中的炎症以及巨噬细胞和中性粒细胞的激活。
Hepatol Commun. 2018 Oct 29;3(1):99-115. doi: 10.1002/hep4.1269. eCollection 2019 Jan.
8
Blockade of TREM-1 prevents vitreoretinal neovascularization in mice with oxygen-induced retinopathy.阻断 TREM-1 可预防氧诱导视网膜病变小鼠的玻璃体内新生血管形成。
Biochim Biophys Acta Mol Basis Dis. 2018 Sep;1864(9 Pt B):2761-2768. doi: 10.1016/j.bbadis.2018.05.001. Epub 2018 May 3.
9
Targeting Intramembrane Protein-Protein Interactions: Novel Therapeutic Strategy of Millions Years Old.靶向跨膜蛋白-蛋白相互作用:数百万年历史的新型治疗策略。
Adv Protein Chem Struct Biol. 2018;111:61-99. doi: 10.1016/bs.apcsb.2017.06.004. Epub 2017 Jul 24.
10
Novel TREM-1 Inhibitors Attenuate Tumor Growth and Prolong Survival in Experimental Pancreatic Cancer.新型 Trem-1 抑制剂可抑制实验性胰腺癌肿瘤生长和延长生存期。
Mol Pharm. 2017 Dec 4;14(12):4572-4582. doi: 10.1021/acs.molpharmaceut.7b00711. Epub 2017 Nov 13.